There are global dynamics at play here. When these agreements were negotiated, every country was trying to secure a supply of vaccines for their country, and there are dynamics in terms of price referencing from one country to another. Each country has different laws and circumstances, and each agreement is different. There are many clauses on things such as pricing and sensitive commercial information and competitive information. We are in a global market dynamic and in a very competitive market dynamic as well, so any clauses that pertain to that are highly confidential and put the business at risk. If the business is at risk, it's the patient's benefit ultimately that will be impacted.
On March 23rd, 2023. See this statement in context.